Tradestie Institutional Equity Comparison Engine

ABVX vs TLX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TLX Overall Edge

TLX Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Telix Pharmaceuticals Limited American Depositary Shares (TLX) driven by superior Valuation, Growth & Margin, Momentum & Technical while ABVX counters with relative strength in Options & Structure. Fundamentally, ABVX trades at N/M Forward P/E with -6270.4% operating margin (-6.8% YoY revenue) versus TLX at N/M Forward P/E and 6.2% operating margin (+22.3% YoY). In options structure, ABVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against TLX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner TLX
ABVX N/M vs TLX N/M Fwd P/E
Growth & Margin Winner TLX
Op Margin -6270.4% vs 6.2% ยท YoY -6.8% vs +22.3%
Momentum & Technical Winner TLX
1Y -17.7% vs -5.8% ยท 52W Pos 17% vs 39%
Options & Structure Winner ABVX
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
ABVX NASDAQ
Abivax SA American Depositary Shares
Pharmaceutical Preparations
$83.06
-5.17% 1D
Market Cap $7.9B
1M Return -5.76%
1Y Return -17.69%
Forward P/E N/M
Unified AI Score
55.6 / 100 HOLD
Tech 42.0 Fund 50.0 Flow 50.0 Mom 50.0
TLX NASDAQ
Telix Pharmaceuticals Limited American Depositary Shares
Pharmaceutical Preparations
$8.96
-2.98% 1D
Market Cap $3.2B
1M Return -16.23%
1Y Return -5.84%
Forward P/E N/M
Unified AI Score
46.4 / 100 HOLD
Tech 64.0 Fund 62.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABVX -17.69% TLX -5.84% Spread: +11.85 pp (TLX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABVX TTM Op. Margin: -6270.4% TLX TTM Op. Margin: 6.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVX vs TLX. Trailing 12-month operating profitability (ABVX -6270.4% vs TLX 6.2%) and valuation multiples (ABVX N/M vs TLX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABVX (3) vs TLX (6)
Institutional Metric ABVX TLX Criterion Row Winner
Market Capitalization Scale $7.9B $3.2B Larger Scale ABVX
Trailing P/E Ratio Valuation N/M 93.6x Lower Multiple TLX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -6.8% +22.3% Higher Growth TLX
Operating Margin (TTM) Profitability -6270.4% 6.2% Higher Margin TLX
Net Profit Margin Profitability 0.0% 3.8% Higher Margin TLX
Return on Equity (ROE) Capital Efficiency -252.3% 7.4% Higher ROE TLX
52-Week Range Position Momentum 17% ($70โ€“$149) 39% ($6โ€“$13) Stronger Trend TLX
Beta / 30D Volatility Risk Regime 1.38ฮฒ ยท 48% Vol 0.84ฮฒ ยท 62% Vol Lower Realized Risk ABVX
Unified Institutional Score Composite Signal 55.6 / 100 (HOLD) 46.4 / 100 (HOLD) Higher Composite ABVX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABVX vs TLX Buy Guide
ABVX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ABVX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TLX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABVX nor TLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.